Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. 

Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS.

We rely on exceptional science, and our focus, always, is on patients.

Biotechnology

Life Sciences

Therapeutics

Kestrel Therapeutics

Kestrel Therapeutics' headquarters in Boston, MA, United States

The Scientific Research team at Kestrel Therapeutics focuses on discovering and developing novel molecules to target intractable cancers, particularly through potent inhibitors of pan-oncogenic-RAS. This team leverages advanced biological, biophysical, and structural biology methods to drive innovative cancer therapies, keeping patient outcomes at the forefront of their research efforts.

Scientific Research

The Leadership Team at Kestrel Therapeutics is responsible for steering the company's strategic direction, overseeing scientific research and development, ensuring seamless operational execution, and managing overall corporate governance. This team plays a critical role in advancing Kestrel’s mission to discover and develop innovative therapies targeting intractable cancers, with a persistent focus on patient outcomes.

Leadership Team

This department manages and oversees the planning and execution of clinical development strategies and operations.

Clinical Development Operations

This department oversees the organization's strategic direction and policy-making through its board members.

��

People (4)

Jobs (0)

Other teams

Leadership Team

Clinical Development Operations

Board Governance

��������

People (4)

Jobs (0)

Other teams

Leadership Team

Clinical Development Operations

Board Governance

��